Remifentanil Hydrochloride Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Remifentanil Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Jun 28, 2022. Reported reason: Delay in shipping of the drug

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-723-03
Dosage Form
Injection
Presentation
Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)
Initial Posting
Jun 28, 2022

Reason

Delay in shipping of the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.